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Canine idiopathic pulmonary fibrosis (CIPF) is a progressive interstitial lung disease mainly 
affecting old West Highland white terriers (WHWTs). CIPF shares several clinical and 
pathological features with human IPF. An imbalance between thrombosis and fibrinolysis has 
been demonstrated in human IPF patients favouring a local and systemic prothrombotic state 
which correlates with disease severity and outcome. The aim of the present study was to 
investigate the coagulation and fibrinolysis systems in CIPF. For this purpose, coagulation 
profile and thromboelastography data were collected and compared between WHWTs 
affected with CIPF and unaffected WHWTs (CTRL). Coagulation times (PT, aPTT), 
plasmatic concentrations of fibrinogen, D dimers, antithrombin III, Protein S and Protein C 
activities, anti-factor Xa activity (FXa), and activated Protein C ratio (APCR) were 
retrospectively measured using the STA Compact automated coagulation analyzer from 
previously stored (-80°C) plasma samples obtained from 20 CTRL and 14 CIPF WHWTs. 
Point-of-care rotational thromboelastometer (ROTEM) was employed to prospectively 
measure clotting-time, α-angle, amplitude at 10/20/30 min, maximal clot firmness, lysis after 
30/60 min, and maximum lysis on whole-citrated blood sampled from 15 CTRL and 9 CIPF 
WHWTs. Satistical analyses were perfomed with a commercially available software using 
Student-t test or Mann-Withney test for continuous variables, and Fisher’s exact test for 
categorical variables. Statistical significance was set at P ≤ 0.05. Compared with CTRL, 
WHWTs affected with CIPF demonstrated a longer aPTT (mean ± SD) (12.2 ± 0.9 sec vs. 
11.5 ± 0.7, P = 0.028), whereas results obtained in both groups were all within reference 
ranges. A trend for an increased fibrinogen concentration (4.1 ± 1.8 g/L vs. 3.1 ± 1.1, P = 
0.067) and for a decreased APCR (median, range) (25.6, 21.9 – 27.7 vs. 26.8, 23.8 – 64.4) in 
WHWTs affected with CIPF was observed, while there was no siginificant difference between 
groups for the other factors assessed. FXa was found above the upper limit of the reference 
range in 3 WHWTs affected with CIPF, but in none of the controls (P = 0.075). ROTEM 
results demonstrated no significant difference between groups for any of the parameters 
studied. Results of the present study provide no clear evidence for a hypercoagulable state in 
WHWTs affected with CIPF. High fibrinogen concentrations found in CIPF WHWTs tend to 
suggest a proinflammatory state which may be a risk factor for thrombosis, but this finding 
should be confirmed by further investigation in larger cohorts of dogs.  
